SCHEMBL28049233

SCHEMBL28049233

COc1ccccc1C(C)NC(=O)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
HPGD P15428 1/20 0.57
L3MBTL1 Q9Y468 2/20 0.56
ROCK2 O75116 1/20 0.56
ROCK1 Q13464 1/20 0.56
CYP1A2 P05177 2/20 0.54
CYP3A4 P08684 2/20 0.54
CYP2C9 P11712 2/20 0.54
CYP2C19 P33261 2/20 0.54
KMT2A Q03164 2/20 0.54
NPC1 O15118 3/20 0.54
RAB9A P51151 2/20 0.54
GAA P10253 1/20 0.53
PKM P14618 1/20 0.53
MEN1 O00255 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
POLB P06746 1/20 0.53
HTT P42858 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
MAPK1 P28482 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27946378 0.83 ROCK1 (0.66) L3MBTL1ROCK2ROCK1CYP3A4CYP2C9
SCHEMBL19658729 0.81 CA1 (0.54) ALDH1A1HPGDL3MBTL1ROCK2ROCK1
SCHEMBL11231448 0.80 SMN1; SMN2 (0.55) ALDH1A1HPGDROCK2ROCK1KMT2A
SCHEMBL19652078 0.80 CA1 (0.53) ALDH1A1HPGDL3MBTL1ROCK2ROCK1
SCHEMBL28196333 0.79 HPGD (0.76) ALDH1A1HPGDL3MBTL1KMT2ANPC1
SCHEMBL28049266 0.79 NPC1 (0.58) ALDH1A1ROCK2ROCK1CYP1A2CYP3A4
SCHEMBL10282632 0.79 CA1 (0.51) ALDH1A1HPGDL3MBTL1ROCK2ROCK1
SCHEMBL1825887 0.78 ALDH1A1 (0.47) ALDH1A1HPGDCYP2C9CYP2C19KMT2A
SCHEMBL19658746 0.77 SMN1; SMN2 (0.56) ALDH1A1HPGDL3MBTL1KMT2AMEN1
SCHEMBL24998749 0.77 MLYCD (0.58) ALDH1A1HPGDCYP1A2CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105358547-A Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors BRISTOL MYERS SQUIBB CO 2016-02-24 CN disclosed